The median level of sPD-1 in the general healthy control group was 45.80 pg/mL (IQR: 33.58–57.31), which was significantly higher than in patients with gastric cancer (median: 11.82; IQR: 7.29–19.84). Here, HOXD13 is linked to gastric cancer.